[HTML][HTML] A cohort of patients with COVID-19 in a major teaching hospital in Europe

…, E Rey Cuevas, C Prados Sánchez… - Journal of clinical …, 2020 - mdpi.com
Background: Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in
January 2020, the epidemic has grown rapidly, with the greatest impact on the region of …

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score

…, M Vendrell, C Prados-Sánchez… - … journal of chronic …, 2017 - Taylor & Francis
Background Although the FACED score has demonstrated a great prognostic capacity in
bronchiectasis, it does not include the number or severity of exacerbations as a separate …

[HTML][HTML] The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

…, MR de Valbuena, C Prados-Sanchez… - Journal of cystic …, 2020 - Elsevier
With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific
patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 …

[HTML][HTML] Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: incidence and results of the national CF-COVID19-Spain survey

…, L Diab-Caceres, C Prados-Sanchez… - Respiratory …, 2020 - Elsevier
Background Given the high incidence of confirmed infection by SARS-CoV-2 and mortality
by COVID-19 in the Spanish population, its impact was analysed among persons with Cystic …

Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

…, C Olveira Fuster, A Padilla Galo, C Prados Sánchez… - Respiration, 2018 - karger.com
Background: Knowing the cost of hospitalizations for exacerbation in bronchiectasis
patients is essential to perform cost-effectiveness studies of treatments that aim to reduce …

COPD assessment test in bronchiectasis: minimum clinically important difference and psychometric validation: a prospective study

…, R Nieto‐Royo, A Navarro‐Rolon, C PradosSánchez… - Chest, 2020 - Elsevier
Background Health-related quality of life (QoL) is one of the most important end points in
bronchiectasis (BE). However, the majority of health-related QoL questionnaires are time-…

[HTML][HTML] Serum interleukin-15 levels in cancer patients with cachexia

…, M Villarino-Sanz, C Prados-Sánchez… - Oncology …, 2012 - spandidos-publications.com
Interleukin-15 (IL-15) has important anabolic effects on muscle protein metabolism through
a decrease in the ATP-ubiquitin-dependent proteolytic pathway. The role of IL-15 in human …

Breaking barriers: prospective study of a cohort of advanced chronic obstructive pulmonary disease patients to describe their survival and end-of-life palliative care …

…, M Varela-Cerdeira, C Prados-Sánchez… - Journal of Palliative …, 2019 - liebertpub.com
Background and Aim: Consensus has been reached on the need to integrate palliative care
in the follow-up examinations of chronic obstructive pulmonary disease (COPD) patients. …

Documento de consenso sobre el diagnóstico y tratamiento de la infección bronquial crónica en la enfermedad pulmonar obstructiva crónica

…, ET Huguet, CÁ Martínez, CP Sánchez… - Archivos de …, 2020 - Elsevier
… a , José Luís López-Campos b c , Bernardino Alcázar Navarrete d , Myriam … Es preferible su
almacenamiento a 4 C que a −20 C 51 . … Es preferible su almacenamiento a 4 C que a −20 C

Kartagener's syndrome. Diagnosis in a 75 year-old woman

…, RAS Walther, CP Sánchez… - Archivos de …, 1999 - pubmed.ncbi.nlm.nih.gov
Kartagener's syndrome is an inherited disease characterized by the clinical triad of bronchiectasis,
sinusitis and situs inversus caused by an ultrastructural defect in the cilia that results …